viernes, 1 de mayo de 2026

AgentClinic puts medical AI through a more realistic diagnostic test

https://www.news-medical.net/news/20260430/AgentClinic-puts-medical-AI-through-a-more-realistic-diagnostic-test.aspx A new benchmark shows that passing medical exams is not enough; clinical AI agents must gather information, handle uncertainty, use tools, interpret images, and navigate bias in simulated patient encounters. A recent study published in the journal npj Digital Medicine introduced a multi-modal agent benchmark, AgentClinic, for clinical artificial intelligence (AI) agents in simulated clinical environments.

AI scribes save clinicians time but fail to reduce overtime work

https://www.news-medical.net/news/20260501/AI-scribes-save-clinicians-time-but-fail-to-reduce-overtime-work.aspx AI scribes promise to ease documentation burden, but new real-world data reveal a more complex reality: modest efficiency gains, unchanged after-hours work, and important questions about how clinicians actually use the time they save. Artificial intelligence (AI)–powered scribes can moderately benefit clinicians by reducing the time to record and document electronic health records and increasing weekly visit volume, as reported in a new study published in JAMA.

Google Search Data Provide Patient-Level View of Dermatologist Access Issues Alicia Ault April 30, 2026

https://www.medscape.com/viewarticle/google-search-data-provide-patient-level-view-dermatologist-2026a1000dth

Why Can’t Europe Kick Its Antibiotic Habit? Sophie Cousins l Medscape Europe April 30, 2026

https://www.medscape.com/viewarticle/why-cant-europe-kick-its-antibiotic-habit-2026a1000dys

DOJ, Elevance spar over access to top exec in Medicare Advantage fraud case Elevance ‘refuses’ to make Peter Haytaian available for deposition, Justice Department says

https://www.statnews.com/2026/04/30/elevance-health-fraud-doj-says-access-blocked-key-witness/ By Bob HermanApril 30, 2026 Bob Herman is the author of Health Care Inc., an award-winning weekly newsletter about the business of health and medicine.

New obesity tool aims to predict risk of 18 serious complications Model goes beyond BMI, using range of signals to say who might benefit from GLP-1 drugs

https://www.statnews.com/2026/04/30/obesity-health-risks-new-tool-obscore-beyond-bmi/ By Elizabeth CooneyApril 30, 2026 Cardiovascular Disease Reporter

What does Akeso’s primo plenary spot say about its survival data? Mystery cloaks an ASCO plenary lung cancer survival result By Adam FeuersteinApril 30, 2026 Senior Writer, Biotech

https://www.statnews.com/2026/04/30/akeso-summit-therapeutics-drug-ivonescimab-results-announced-asco/